BRIAN KILMEADE (CO-HOST): Let's just talk about an Axios report that yesterday in the situation room you walked in very proud of acquiring more hydroxychloroquine and Dr. Fauci was very negative on it and evidently you guys had a heated exchange. Can you shed some light on that for us?
PETER NAVARRO (WHITE HOUSE TRADE ADVISER): Sure. There was no pride there, it was simply on Saturday there was a meeting of the task force and the question before the task force was this, Brian. We have 29 million tablets, 29 million tablets of hydroxy in FEMA warehouses and the question before the group was should we surge that hydroxy into the hot zones, and the task force unanimously voted to do that, with the proviso that this can have side effects and that it has to be dispensed not by the federal government but by the patient-doctor relationship. The third thing I can tell you about the meeting and the discussion was there was some discussion about the numerous studies that are out with regard to efficacy. It is true there's no 100% proof that this works. On the other hand, there's numerous studies that are coming out now including the latest one which is randomized that shows therapeutic efficacy. The other thing I should tell you is that in the city of New York, if you're a patient in the New York health and hospital system, which is 11 hospitals run by Dr. Mitch Katz, any patient, virtually every patient that presents with COVID-19 is given a cycle of hydroxy, and when I asked Dr. Katz why, was it because the federal government was telling you to do that or because he thought it may work, and he said very clearly that it may work. So that was the sum and substance of the discussion. The media is trying to blow it up as a big, big debate, but I can tell you that within the room, the decision was a sound one and it was unanimous.
AINSLEY EARHARDT (CO-HOST): So what does Dr. Fauci want? Does he want more testing?
NAVARRO: Look, I'll let Tony speak for himself. You've seen he takes the view that it's important to have controlled studies, randomized studies and to go through the science and come to the end and determine what's going on, and as a social scientist myself I totally agree with that. But there's also the point of view that we are in war. President Trump is a wartime president. In the fog of war, we might take more risk than we otherwise would. And given the track record of the drug over many, many years treating malaria -- and there are side effects, but it’s been used a lot in lesser doses -- the decision has been made by many doctors to prescribe it, and if it saves lives that's a beautiful thing. I think history will judge who’s right on this debate, but I'd bet on President Trump's intuition on this one, because of all the doctors I've talked to and all the scientific papers I've read and they're about this high.
STEVE DOOCY (CO-HOST): Yeah. Of course that's the conversation that every patient needs to have with their doctor to figure out what is the best care for them.
NAVARRO: Yes, sir. Absolutely.